According to Globus Medical's latest financial reports the company has $0.51 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.51 B | 16.08% |
2022-12-31 | $0.44 B | 0.59% |
2021-12-31 | $0.44 B | 3.91% |
2020-12-31 | $0.42 B | 37% |
2019-12-31 | $0.31 B | -8.27% |
2018-12-31 | $0.33 B | -9.13% |
2017-12-31 | $0.37 B | 28.73% |
2016-12-31 | $0.29 B | 3.3% |
2015-12-31 | $0.28 B | 22.88% |
2014-12-31 | $0.22 B | -4.28% |
2013-12-31 | $0.23 B | 12.49% |
2012-12-31 | $0.21 B | 48.88% |
2011-12-31 | $0.14 B | 27.72% |
2010-12-31 | $0.11 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Stryker Corporation SYK | $3.05 B | 489.62% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | $33.1 M | -93.61% | ๐บ๐ธ USA |
NuVasive NUVA | $80.71 M | -84.41% | ๐บ๐ธ USA |